University of California
Howard J Federoff over sees the clinical, medical educational, and research missions, as a Vice Chancellor for Health Affairs and CEO of UC Irvine Health. He investigates gene therapy and neurodegenerative diseases. He has published greater than 250 articles and serves on the editorial boards of five journals. He Chaired the NIH Recombinant DNA Advisory Committee and currently Chairs the Gene Therapy Resource Program for NHLBI. He is President of the American Society for Experimental Neurotherapeutics. He received MS, PhD, and MD degrees from the Albert Einstein College of Medicine, did his internship, residency, and clinical and research fellowships at Massachusetts General Hospital/Harvard Medical School. He is a Fellow of the AAAS and National Academy of Inventors.
Federoff also has advanced research in the areas of gene therapy and neurodegenerative disorders such as Alzheimer's, Parkinsonâ€™s and prion diseases. He holds a number of medical patents, with several other patents pending.